. Author manuscript; available in PMC: 2021 Feb 1.

Published in final edited form as: J Drug Deliv Sci Technol. 2019 Nov 8;55:101374. doi: 10.1016/j.jddst.2019.101374

Table 6B:

Comparison of IC₅₀ values of GemHCl and Gem-SLN₁₅ treated MiaPaCa-2 and PPCL-46 groups based on one-way ANOVA followed by Turkey post-test

Group comparison	P-value	Significant?
Gem-SLN₁₅ treated-2D MiaPaCa-2 vs GemHCl treated-2D MiaPaCa-2	0.026	Yes
Gem-SLN₁₅ treated-3D MiaPaCa-2 vs GemHCl treated-3D MiaPaCa-2	0.025	Yes
Gem-SLN₁₅ treated-2D PPCL-46 vs GemHCl treated-2D PPCL-46	0.001	Yes
Gem-SLN₁₅ treated-3D PPCL-46 vs GemHCl treated-3D PPCL-46	0.001	Yes

The IC₅₀ values of Gem-SLN₁₅ treated cancer cells were significantly lower than GemHCl treated cancer cells.

P< 0.05

^**

P< 0.01

^***

P< 0.001